Inflammation Proteins May Lead to ALS: Study

Harvard Medical School

For physicians, scientists, and patients, neurodegenerative diseases, which affect millions of people in this country and hundreds of millions across the world, remain a formidable foe. An array of treatments can help alleviate symptoms and slow progression, but a cure has remained elusive.

  • By GINA MANTICA | Boston Children’s Hospital

Now, researchers at Harvard Medical School and Boston Children’s Hospital have identified proteins involved in the innate immune system that could be at the root of a range of neurodegenerative conditions.

The findings, based on experiments in mice and human nerve cells and published March 13 in Neuron, point to new pathways for slowing neuronal dysfunction and treating amyotrophic lateral sclerosis (ALS), a fatal motor neuron disease.

Specifically, the researchers found that inactivating a molecule in the brain linked to inflammation prevents cellular damage in human neurons and delays the progression of ALS in mice.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.